Evidence map›Paper›PMID 27376549›Full record

ArticleeLife2016

Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells.

Karmel A Allison, Eniko Sajti, Jana G Collier, David Gosselin, Ty Dale Troutman, Erica L Stone, Stephen M Hedrick, Christopher K Glass

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antigen perception in T cells by long-term Erk and NFAT signaling dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Karmel A AllisonDepartment of Cellular and Molecular Medicine, University of California, San Diego, United States.
Eniko SajtiDepartment of Pediatrics, University of California, San Diego, United States.
Jana G CollierDepartment of Cellular and Molecular Medicine, University of California, San Diego, United States.
David GosselinDepartment of Cellular and Molecular Medicine, University of California, San Diego, United States.
Ty Dale TroutmanDepartment of Cellular and Molecular Medicine, University of California, San Diego, United States.
Erica L StoneMolecular Biology Section, Division of Biological Science, University of California, San Diego, United States.
Stephen M HedrickDepartment of Cellular and Molecular Medicine, University of California, San Diego, United States.
Christopher K GlassDepartment of Cellular and Molecular Medicine, University of California, San Diego, United States.ORCID 0000-0003-4344-3592
University of California San Diego · USThe Wistar Institute · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
SYNTHETIC SYSTEMSP50GM085764 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HASTY, JEFF M, IDEKER, TREY · 2010 to 2018
$23.3M
Transcriptional Genomics CoreP01DK074868 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2007 to 2016
$16.6M
Contemporary Approaches to Cancer Cell Signaling and CommunicationT32CA009523 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DONOGHUE, DANIEL J, YANG, JING · 1985 to 2025
$12.1M
Transcriptional co-regulators and macrophage gene expressionR01DK091183 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2011 to 2025
$9.9M
Enhancer TherapyR01CA173903 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2012 to 2016
$6.3M
A molecular basis for control of T cell memoryR01AI103440 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEDRICK, STEPHEN M · 2013 to 2017
$2.3M
Control of Lymphocyte Homeostasis by Foxo Transcription FactorsR01AI073885 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEDRICK, STEPHEN M · 2009 to 2010
$873k
Regulation of Adipose Tissue Inflammation and Insulin Resistance by T Cell SubsetK01DK095008 · NIDDK · WISTAR INSTITUTE · PI STONE, ERICA LYN · 2012 to 2015
$662k
Toward enhancer therapy: Finding the keystone enhancers that distinguish CD4+ T cF31AI112269 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALLISON, KARMEL · 2014 to 2015
$52k
NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA173903NCI NIH HHS T32 CA009523NIAID NIH HHS F31 AI112269NIAID NIH HHS R01 AI073885NIAID NIH HHS R01 AI103440NIDDK NIH HHS K01 DK095008NIDDK NIH HHS P01 DK074868NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK091183NIGMS NIH HHS P50 GM085764
6 · The paper itself

Abstract

Affinity and dose of T cell receptor (TCR) interaction with antigens govern the magnitude of CD4+ T cell responses, but questions remain regarding the quantitative translation of TCR engagement into downstream signals. We find that while the response of mouse CD4+ T cells to antigenic stimulation is bimodal, activated cells exhibit analog responses proportional to signal strength. Gene expression output reflects TCR signal strength, providing a signature of T cell activation. Expression changes rely on a pre-established enhancer landscape and quantitative acetylation at AP-1 binding sites. Finally, we show that graded expression of activation genes depends on ERK pathway activation, suggesting that an ERK-AP-1 axis plays an important role in translating TCR signal strength into proportional activation of enhancers and genes essential for T cell function.

Indexed as

Gene ExpressionAnimalsAntigensCD4-Positive T-LymphocytesLymphocyte ActivationMiceReceptors, Antigen, T-CellSignal TransductionAntigensReceptors, Antigen, T-Cellcomputational biologyenhancersimmunologymouseprotein kinasesystems biologytranscription factors

Identifiers

PMID27376549
PMCPMC4931909
OpenAlexW2465973416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.